Polomar Health Services (PMHS) Total Non-Current Liabilities (2023 - 2025)
Polomar Health Services (PMHS) posted Total Non-Current Liabilities of $5986.0 for Q1 2025, down 59.73% on a QoQ basis from $14864.0 in Q4 2024, and down 79.83% year-over-year from $29682.0 in Q1 2024.
Powered by 
Analysis
Polomar Health Services (PMHS) Total Non-Current Liabilities (2023 - 2025) Analysis & Trends
Polomar Health Services has reported Total Non-Current Liabilities for 3 years, with the latest figure at $5986.0 in Q1 2025.
- On a quarterly basis, Total Non-Current Liabilities fell 79.83% year-over-year to $5986.0 in Q1 2025; TTM through Mar 2025 was $5986.0, a 79.83% decrease from a year earlier, with the FY2024 full-year figure at $14864.0, down 69.78% from the prior year.
- Total Non-Current Liabilities was $5986.0 for Q1 2025 at Polomar Health Services, down from $14864.0 in the prior quarter.
- The five-year high for Total Non-Current Liabilities was $49180.0 in Q4 2023, with the low at $5986.0 in Q1 2025.
- Average Total Non-Current Liabilities over 3 years is $24355.7, with a median of $23211.0 recorded in 2024.
- The sharpest annual moves came in 2024 and 2025: Total Non-Current Liabilities tumbled 69.78% in 2024, then slumped 79.83% in 2025.
- Over 3 years, Total Non-Current Liabilities stood at $49180.0 in 2023, then sank by 69.78% to $14864.0 in 2024, then plunged by 59.73% to $5986.0 in 2025.
- The last three Total Non-Current Liabilities figures came in at $5986.0 (Q1 2025), $14864.0 (Q4 2024), and $23620.0 (Q3 2024), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.84 Bn | 39.19 Bn | 2.15 Bn | 16.45 Bn |
| 2 | Viatris | 19.13 Bn | 18.24 Bn | 1.46 Bn | 18.76 Bn |
| 3 | Dr Reddys Laboratories | 9.91 Bn | 9.74 Bn | 396.53 Mn | 1.29 Mn |
| 4 | Amneal Pharmaceuticals | 5.51 Bn | 5.38 Bn | 334.51 Mn | 2.78 Bn |
| 5 | Bausch Health Companies | 2.30 Bn | 464.50 Mn | 2.10 Bn | 24.86 Bn |
| 6 | Alvotech | 1.50 Bn | 1.36 Bn | 2.56 Mn | 1.45 Bn |
| 7 | Ani Pharmaceuticals | 1.49 Bn | 1.13 Bn | 165.89 Mn | 881.37 Mn |
| 8 | Amphastar Pharmaceuticals | 1.00 Bn | 714.13 Mn | 93.47 Mn | 946.17 Mn |
| 9 | Fennec Pharmaceuticals | 402.10 Mn | 360.85 Mn | 17.15 Mn | 20.92 Mn |
| 10 | Polomar Health Services | 5.66 Mn | 5.48 Mn | 935,916.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2025 | 5,986.00 |
| Dec 31, 2024 | 14,864.00 |
| Sep 30, 2024 | 23,620.00 |
| Jun 30, 2024 | 22,802.00 |
| Mar 31, 2024 | 29,682.00 |
| Dec 31, 2023 | 49,180.00 |